{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreietnznth73nut2efs6ybxbrn6bcbqetzhsukea3qeaasrvanva6t4",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mjnelisnuwt2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreif2yjrxxafe54wphu6qb63nnwk7sw36cipugoouyaeslmytlpagbe"
    },
    "mimeType": "image/webp",
    "size": 83960
  },
  "path": "/releases/2026/04/260415043617.htm",
  "publishedAt": "2026-04-16T05:19:45.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some widely used medications—including antidepressants and certain antidiarrheal drugs—were linked to a small but noticeable increase in the risk of death over time.",
  "title": "Common IBS medications linked to higher risk of death in major study"
}